Skip to main content
Amy Duffield, MD, Pathology, Baltimore, MD, Memorial Sloan Kettering Cancer Center

AmySusanDuffieldMD

Pathology Baltimore, MD

Hematopathology, Anatomic Pathology, Clinical Pathology

Professor of Pathology, Icahn School of Medicine at Mount Sinai Hospital

Dr. Duffield is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Duffield's full profile

Already have an account?

  • Office

    401 North Broadway
    Pathology, Weinberg Building, Suite 2242
    Baltimore, MD 21231
    Phone+1 410-955-3580
  • Is this information wrong?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematopathology, 2009 - 2010
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2005 - 2009
  • Yale School of Medicine
    Yale School of MedicineClass of 2005

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2020 - 2025
  • NJ State Medical License
    NJ State Medical License 2021 - 2023
  • MD State Medical License
    MD State Medical License 2010 - 2020
  • PA State Medical License
    PA State Medical License 2008 - 2010
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Hematopathology

Publications & Presentations

PubMed

Abstracts/Posters

  • The High Mobility Group A1 Chromatin Regulator Is Required for Pathologic Megakaryocyte Development and Progression to Myelofibrosis in JAK2V617F Murine Models
    Amy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • DOCK2 Expression Affects Leukemogenesis and Disease Progression in a Murine Model of FLT3/ITD Acute Myeloid Leukemia
    Amy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Gilteritinib and Venetoclax Synergize to Eliminate FLT3/ITD+ Leukemia Cells through BIM
    Amy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Journal of Hematopathology
    Journal of HematopathologyFebruary 20th, 2019
  • Researchers Link Organ Transplant Drug to Rise in Rare Lymphoma
    Researchers Link Organ Transplant Drug to Rise in Rare LymphomaFebruary 10th, 2016

Hospital Affiliations